Telaprevir's Efficacy Against Hepatitis C Trumps Standard Treatment
April 14, 2010
Results of the PROVE3 trial found that drug regimens using telaprevir were more effective against Hepatitis C than regimens without telaprevir in both treatment naïve patients and previous treatment non-responders.
Mid-stage trial notes efficacy in investigational hepatitis C treatment
By Alaric DeArment
CORK, Ireland (Apr. 9) Patients with chronic genotype 1 hepatitis C fared better when given an investigational drug developed by Johnson & Johnson division Tibotec and Vertex Pharmaceuticals than when given the standard therapy, after they had failed previous treatments, according to results of a mid-stage trial published Thursday.
The results of the 453-patient, phase 2 "PROVE3" trial, published in the New England Journal of Medicine, found that regimens based on the drug telaprevir worked better than other drugs at keeping the virus undetectable in the bloodstream.
Continue reading this entire article:
http://drugstorenews.com/story.aspx?id=136035&menuid=345
Posted by Editors at April 14, 2010 8:43 AM
Site Topics
Frequently Asked Questions
Some of our most commonly asked questions and our answers to them.
What Is Hepatitis C?
Learn about the Hepatitis C Virus (HCV).
Hepatitis C Transmission
Information about the transmission of Hepatitis C.
Hepatitis C Symptoms
You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.
Hepatitis C Conventional Treatment
Learn about the conventional medical treatments used to fight Hepatitis C.
Hepatitis C Medicines
Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.
Hepatitis C Natural Remedies
A number of herbal products useful in the management of liver disease.
Hepatitis Central News Signup
Receive the latest news on hepatitis treatments, clinical trials, social issues and important breakthroughs.
Hepatitis C Genotypes
Learn about Hepatitis C Genotypes and their variants.
Hepatitis C Doctors
A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.
Hepatitis C Links
Convenient links to other sites external to Hepatitis-Central.
Hepatitis C Forum
A Bulletin Board for discussions on hepatitis, treatments, etc.
Hepatitis C Activism
An easy way to get involved in urging our government to do more for Hepatitis C awareness and treatment research.
Hepatitis B
Numerous links to various Hepatitis B related information, including transmission, symptoms and treatment.
Biopsy Information
A comprehensive resource of information relating to the liver biopsy.
Cirrhosis
Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.
Glossary
Commonly used medical terms and definitions.
Lab Tests
What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.
Liver Cancer
Liver Cancer/Hepatocellular Carcinoma studies, info sheets, FAQs, and analysis.
Liver Disease and Drugs
An exhaustive list of links to studies, info sheets, FAQs, and analysis of the various drugs used to treat liver disease.
Viral Load
Provides detailed information on how to analyze and interpret viral load numbers as well as a link to a convenient Viral Load Chart.
What is...?
Learn more about various Hepatitis C related topics, including HCV, Ascites, Biopsies, and much more.
Hepatitis C Books
Recommended reading for those interested in hepatitis information.
Advertisement
Advertisement(s)
Site Topics
HCV Symptoms, Lab Tests, Hepatitis C Genotypes, Glossary, Viral Load, What is...?, HCV Medicines, Hepatitis C Doctors, Biopsy Info, Cirrhosis, Liver Cancer, Liver Disease Medicines, Hep-Central Email List, HCV Links, Mother / Child Transmission, HCV Natural Remedies, HCV Books, Hepatitis C Forum, Hepatitis C Activism
Copyright ©1994-2012 Hepatitis Central. Information at this website is for educational purposes only; statements about products and health conditions have not been evaluated by the U.S. Food & Drug Administration.